114 Followers on Owler
OverviewCompetitorsFundingNews & Insights

PhaseBio Funding History

Since PhaseBio was founded in 2002, it has participated in 9 rounds of funding. In total PhaseBio has raised $204.1M. PhaseBio's last funding round was on Oct 2018 for a total of $46.0M.

PhaseBio Funding Rounds

PhaseBio Investors

Unlock 10 more investors →

INVESTOR

ROUND

FUNDING DATE

Rock Springs Capital
Series D
Sep 2018
Mountain Group Partners
Series D
Sep 2018
New Enterprise Associates
Series D, Debt, Convertible Note, Series C, Series B
Sep 2018, Nov 2017, Jan 2017, Feb 2015, Jun 2012, Dec 2009
Hatteras Venture Partners
Series D, Debt, Convertible Note, Series C, Series B
Sep 2018, Nov 2017, Jan 2017, Feb 2015, Jun 2012, Dec 2009
AstraZeneca
Series D, Debt, Convertible Note
Sep 2018, Nov 2017, Jan 2017

Total Investors: 13

PhaseBio has 13 investors, including Rock Springs Capital, Mountain Group Partners and New Enterprise Associates. The latest investment occurred in Oct 2018.